These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23417242)

  • 1. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.
    Qu F; Cui X; Hong Y; Wang J; Li Y; Chen L; Liu Y; Gao Y; Xu D; Wang Q
    Mol Cell Biochem; 2013 May; 377(1-2):121-30. PubMed ID: 23417242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
    Kong Q; Chen XS; Tian T; Xia XY; Xu P
    Oncol Rep; 2017 Feb; 37(2):803-812. PubMed ID: 27959429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.
    Jin F; Fondell JD
    Nucleic Acids Res; 2009 Aug; 37(14):4826-38. PubMed ID: 19520769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
    Yin Y; Cai J; Meng F; Sui C; Jiang Y
    Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
    Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
    Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C; Yinghao S; Li J
    Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.
    Shiina M; Hashimoto Y; Kato T; Yamamura S; Tanaka Y; Majid S; Saini S; Varahram S; Kulkarni P; Dasgupta P; Mitsui Y; Sumida M; Tabatabai L; Deng G; Kumar D; Dahiya R
    Oncotarget; 2017 Jan; 8(5):8356-8368. PubMed ID: 28039468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
    Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
    Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
    Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
    Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
    Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
    Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
    Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.
    Chiyomaru T; Tatarano S; Kawakami K; Enokida H; Yoshino H; Nohata N; Fuse M; Seki N; Nakagawa M
    Prostate; 2011 Oct; 71(14):1559-67. PubMed ID: 21360565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation.
    Kim SJ; Choi H; Park SS; Chang C; Kim E
    Mol Cells; 2011 Apr; 31(4):371-7. PubMed ID: 21331774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
    Zheng L; Kang Y; Zhang L; Zou W
    Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth.
    Ribas J; Ni X; Haffner M; Wentzel EA; Salmasi AH; Chowdhury WH; Kudrolli TA; Yegnasubramanian S; Luo J; Rodriguez R; Mendell JT; Lupold SE
    Cancer Res; 2009 Sep; 69(18):7165-9. PubMed ID: 19738047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.